Juan C. Cruz-Huerta
Mexico City, DIF 14080, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Modulation of the Antitumor Response to Metformin, Caffeine, and Sodium Dichloroacetate by the Hypoxic Microenvironment in Lung Cancer Cells.
Journal: International journal of molecular sciences
Published: April 12, 2025
Evaluation of the Antinociceptive Effect of Sesamin: Role of 5HT1A Serotonergic Receptors.
Journal: Pharmaceutics
Published: January 21, 2025
Anti-inflammatory effect of free and microencapsulated extract of Lippia graveolens Kunth in a carrageenan-induced paw edema model and an ovalbumin-induced asthma model in mice.
Journal: Journal of ethnopharmacology
Published: December 18, 2024
Development of a Novel Co-Amorphous Curcumin and L-Arginine (1:2): Structural Characterization, Biological Activity and Pharmacokinetics.
Journal: Pharmaceutics
Published: November 07, 2024
MUC5B rs35705950 Promoter Variant Is Associated with Usual Interstitial Pneumonia in Patients with Antisynthetase Syndrome.
Journal: Journal of clinical medicine
Published: August 29, 2024
Rational use of short-term anorectic drugs for one-year effective treatment of obesity: An analysis of four studies.
Journal: International journal of clinical pharmacology and therapeutics
Published: July 24, 2024
Comparative Effects of Gymnema sylvestre and Berberine on Adipokines, Body Composition, and Metabolic Parameters in Obese Patients: A Randomized Study.
Journal: Nutrients
Published: June 16, 2024
Association between anti-PL7 antibodies and increased fibrotic component in patients with antisynthetase syndrome and interstitial lung disease: a cross-sectional study.
Journal: Clinical rheumatology
Published: January 31, 2024
Corrigendum to Article CP203292.
Journal: International journal of clinical pharmacology and therapeutics
Published: June 27, 2023
Ivermectin: A Controversial Focal Point during the COVID-19 Pandemic.
Journal: Life (Basel, Switzerland)
Published: August 03, 2022
Metformin improves the weight reduction effect of mazindol in prediabetic obese Mexican subjects.
Journal: International journal of clinical pharmacology and therapeutics
Published: June 30, 2022
Combined First Month Body Weight Loss and Development of Tolerance as Predictors of 6-Month Efficacy of Mazindol in Mild and Moderate Obese Subjects.
Journal: Journal of clinical medicine
Published: March 30, 2022
Last Updated: 09/26/2026